Abiopharma

News list

Bodenstedt Matthias 🟢 acquired 354.3K shares of MoonLake Immunotherapeutics (MLTX) Transaction Date: Jan 07, 2026 | Filing ID: 002907

Full text

News bot Jan. 9, 2026, 9:02 p.m.
🔍 Bodenstedt Matthias (Executive)

Company: MoonLake Immunotherapeutics (MLTX)

Report Date: 2026-01-07
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 354,296
Detailed Transactions and Holdings:
- Acquired 354,296 shares of Class A ordinary shares, par value $0.0001 per share (Direct)
  Date: 2026-01-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,276,305.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents shares of restricted stock that vest in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.